BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rieder F, Fiocchi C, Rogler G. Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. Gastroenterology 2017;152:340-350.e6. [PMID: 27720839 DOI: 10.1053/j.gastro.2016.09.047] [Cited by in Crossref: 239] [Cited by in F6Publishing: 237] [Article Influence: 39.8] [Reference Citation Analysis]
Number Citing Articles
1 Lim HJ, Park IS, Jeong SJ, Ha GS, Yang HJ, Jeong DY, Kim SY, Jung CH. Effects of Cheonggukjang (Fermented Soybean) on the Development of Colitis-Associated Colorectal Cancer in Mice. Foods 2023;12. [PMID: 36673473 DOI: 10.3390/foods12020383] [Reference Citation Analysis]
2 Ren LL, Li XJ, Duan TT, Li ZH, Yang JZ, Zhang YM, Zou L, Miao H, Zhao YY. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities. Chem Biol Interact 2023;369:110289. [PMID: 36455676 DOI: 10.1016/j.cbi.2022.110289] [Reference Citation Analysis]
3 Manski SA, Schlachterman A. Bypass of a Duodenal Stricture in Crohn's Disease Using a Lumen Opposing Metal Stent (LAMS): A Case Report. Inflamm Bowel Dis 2023;29:177-8. [PMID: 36069906 DOI: 10.1093/ibd/izac192] [Reference Citation Analysis]
4 Park JM, Kim J, Lee YJ, Bae SU, Lee HW. Inflammatory bowel disease-associated intestinal fibrosis. J Pathol Transl Med 2023;57:60-6. [PMID: 36623814 DOI: 10.4132/jptm.2022.11.02] [Reference Citation Analysis]
5 Mao R, Liu Z, Rieder F. The Effects of Mesenteric Inflammation on Intestinal Fibrosis. The Mesentery and Inflammation 2023. [DOI: 10.1007/978-3-031-17774-3_9] [Reference Citation Analysis]
6 Yin Y, Xie Y, Ge W, Li Y. Creeping fat formation and interaction with intestinal disease in Crohn's disease. United European Gastroenterol J 2022;10:1077-84. [PMID: 36507842 DOI: 10.1002/ueg2.12349] [Reference Citation Analysis]
7 Colucci R, Fornai M, Antonioli L, Segnani C, Ippolito C, Pellegrini C, Nericcio A, Zizzo MG, Serio R, Blandizzi C, Bernardini N. Role of cyclooxygenase pathways in bowel fibrotic remodelling in a murine model of experimental colitis. Journal of Pharmacy and Pharmacology 2022. [DOI: 10.1093/jpp/rgac073] [Reference Citation Analysis]
8 El Ouali S, Baker ME, Lyu R, Fletcher JG, Bruining DH, Holubar SD, Click B, Qazi T, Cohen BL, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Validation of stricture length, duration and obstructive symptoms as predictors for intervention in ileal stricturing Crohn's disease. United European Gastroenterol J 2022;10:958-72. [PMID: 36479841 DOI: 10.1002/ueg2.12314] [Reference Citation Analysis]
9 Wang YD, Zhang RN, Mao R, Li XH. Inflammatory bowel disease cross-sectional imaging: What's new? United European Gastroenterol J 2022;10:1179-93. [PMID: 36461914 DOI: 10.1002/ueg2.12343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sleiman J, Chirra P, Gandhi NS, Baker ME, Lu C, Gordon IO, Viswanath SE, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Crohn's disease related strictures in cross-sectional imaging: More than meets the eye? United European Gastroenterol J 2022;10:1167-78. [PMID: 36326993 DOI: 10.1002/ueg2.12326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yamamoto H, Yano T, Araki A, Esaki M, Ohtsuka K, Ohmiya N, Oka S, Nakase H, Bamba S, Hirai F, Hosoe N, Matsuda T, Mitsui K, Watanabe K, Ogata H, Katsuki S, Matsumoto T, Fujishiro M, Fujimoto K, Inoue H. Guidelines for endoscopic balloon dilation in treating Crohn's disease-associated small intestinal strictures (supplement to the Clinical Practice Guidelines for Enteroscopy). Dig Endosc 2022;34:1278-96. [PMID: 36073310 DOI: 10.1111/den.14429] [Reference Citation Analysis]
12 Lin Q, Li C, Wang L, Cai H, Tang L, Gu Y. Ultrasensitive near-infrared fluorescence probe activated by nitroreductase for in vivo hypoxia detection. Sensors and Actuators B: Chemical 2022;371:132521. [DOI: 10.1016/j.snb.2022.132521] [Reference Citation Analysis]
13 Welz L, Aden K. Fibrosis and Inflammation in Inflammatory Bowel Disease-More Than 2 Sides of the Same Coin? Gastroenterology 2022:S0016-5085(22)01246-X. [PMID: 36341736 DOI: 10.1053/j.gastro.2022.10.024] [Reference Citation Analysis]
14 Flannigan KL, Nieves KM, Szczepanski HE, Serra A, Lee JW, Alston LA, Ramay H, Mani S, Hirota SA. The Pregnane X Receptor and Indole-3-Propionic Acid Shape the Intestinal Mesenchyme to Restrain Inflammation and Fibrosis. Cell Mol Gastroenterol Hepatol 2022;15:765-95. [PMID: 36309199 DOI: 10.1016/j.jcmgh.2022.10.014] [Reference Citation Analysis]
15 Liu A, Guo J, Liu H, Xu Y, Wu J, Mao T, Tian Z, Ding X. Ustekinumab is effective against ulcerative colitis with intestinal stenosis: A case report. Medicine (Baltimore) 2022;101:e31213. [PMID: 36281114 DOI: 10.1097/MD.0000000000031213] [Reference Citation Analysis]
16 Tavares de Sousa H, Carneiro F. Understanding progression of strictures in ileal Crohn's disease-The importance of setting methodological standards. United European Gastroenterol J 2022;10:915-6. [PMID: 36251489 DOI: 10.1002/ueg2.12327] [Reference Citation Analysis]
17 Loras C. Endoscopic Stenting for Inflammatory Bowel Disease Strictures. Gastrointestinal Endoscopy Clinics of North America 2022;32:699-717. [DOI: 10.1016/j.giec.2022.04.004] [Reference Citation Analysis]
18 Bartlett DJ, Ramos GP, Fletcher JG, Bruining DH. Imaging Evaluation of Inflammatory Bowel Disease Complications. Gastrointestinal Endoscopy Clinics of North America 2022;32:651-73. [DOI: 10.1016/j.giec.2022.05.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Zeng C, Liu X, Xiong D, Zou K, Bai T. Resolvin D1 Prevents Epithelial-to-Mesenchymal Transition and Reduces Collagen Deposition by Stimulating Autophagy in Intestinal Fibrosis. Dig Dis Sci 2022;67:4749-59. [PMID: 35013877 DOI: 10.1007/s10620-021-07356-w] [Reference Citation Analysis]
20 Liu N, Kou L, Liu Y, Bo S, jing M. Xanthones from Gentianopsispaludosa(Hook. f.) Ma ameliorates colonic epithelial-mesenchymal transition through regulating autophagy.. [DOI: 10.21203/rs.3.rs-2053950/v1] [Reference Citation Analysis]
21 Delfini M, Stakenborg N, Viola MF, Boeckxstaens G. Macrophages in the gut: Masters in multitasking. Immunity 2022;55:1530-48. [PMID: 36103851 DOI: 10.1016/j.immuni.2022.08.005] [Reference Citation Analysis]
22 Lin SN, Musso A, Wang J, Mukherjee PK, West GA, Mao R, Lyu R, Li J, Zhao S, Elias M, Haberman Y, Denson LA, Kugathasan S, Chen MH, Czarnecki D, Dejanovic D, Le HT, Chandra J, Lipman J, Steele SR, Nguyen QT, Fiocchi C, Rieder F. Human Intestinal Myofibroblasts DepositED COLLAGEN VI EnhanceS Adhesiveness for T cells - A Novel Mechanism for Maintenance of Intestinal Inflammation. Matrix Biol 2022:S0945-053X(22)00113-5. [PMID: 36108990 DOI: 10.1016/j.matbio.2022.09.001] [Reference Citation Analysis]
23 Laudadio I, Bastianelli A, Fulci V, Carissimi C, Colantoni E, Palone F, Vitali R, Lorefice E, Cucchiara S, Negroni A, Stronati L. ZNF281 Promotes Colon Fibroblast Activation in TGFβ1-Induced Gut Fibrosis. IJMS 2022;23:10261. [DOI: 10.3390/ijms231810261] [Reference Citation Analysis]
24 Levy AN. Diagnosis and Classification of Inflammatory Bowel Disease Strictures. Gastrointestinal Endoscopy Clinics of North America 2022. [DOI: 10.1016/j.giec.2022.04.001] [Reference Citation Analysis]
25 Yuan G, He Y, Cao QH, Tang MM, Xie ZL, Qiu Y, Zeng ZR, Peng S, Chen MH. Visceral adipose volume is correlated with surgical tissue fibrosis in Crohn's disease of the small bowel. Gastroenterol Rep (Oxf) 2022;10:goac044. [PMID: 36042948 DOI: 10.1093/gastro/goac044] [Reference Citation Analysis]
26 Zhang J, Ou A, Tang X, Wang R, Fan Y, Fang Y, Zhao Y, Zhao P, Chen D, Wang B, Huang Y. "Two-birds-one-stone" colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis. J Nanobiotechnology 2022;20:389. [PMID: 36042499 DOI: 10.1186/s12951-022-01598-0] [Reference Citation Analysis]
27 Pronio A, Covotta F, Pallotta L, Palma R, Badiali D, Sacchi MC, Lamazza A, Severi C. Eosinophilic Esophagitis: Cytokines Expression and Fibrotic Markers in Comparison to Celiac Disease. Diagnostics 2022;12:2092. [DOI: 10.3390/diagnostics12092092] [Reference Citation Analysis]
28 Xiong S, Tan J, Wang Y, He J, Hu F, Wu X, Liu Z, Lin S, Li X, Chen Z, Mao R. Fibrosis in fat: From other diseases to Crohn’s disease. Front Immunol 2022;13:935275. [DOI: 10.3389/fimmu.2022.935275] [Reference Citation Analysis]
29 Amamou A, Yaker L, Leboutte M, Bôle-feysot C, Savoye G, Marion-letellier R. Dietary AhR Ligands Have No Anti-Fibrotic Properties in TGF-β1-Stimulated Human Colonic Fibroblasts. Nutrients 2022;14:3253. [DOI: 10.3390/nu14163253] [Reference Citation Analysis]
30 Huang L, Qian W, Xu Y, Guo Z, Yin Y, Guo F, Zhu W, Li Y. Mesenteric Adipose Tissue Contributes to Intestinal Fibrosis in Crohn's Disease Through the ATX-LPA Axis. J Crohns Colitis 2022;16:1124-39. [PMID: 35104318 DOI: 10.1093/ecco-jcc/jjac017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
31 Steiner CA, Cartwright IM, Taylor CT, Colgan SP. Hypoxia-inducible factor (HIF) as a bridge between healthy barrier function, wound healing, and fibrosis. Am J Physiol Cell Physiol 2022. [PMID: 35912990 DOI: 10.1152/ajpcell.00227.2022] [Reference Citation Analysis]
32 Golusda L, Kühl AA, Lehmann M, Dahlke K, Mueller S, Boehm-sturm P, Saatz J, Traub H, Schnorr J, Freise C, Taupitz M, Biskup K, Blanchard V, Klein O, Sack I, Siegmund B, Paclik D. Visualization of Inflammation in Experimental Colitis by Magnetic Resonance Imaging Using Very Small Superparamagnetic Iron Oxide Particles. Front Physiol 2022;13:862212. [DOI: 10.3389/fphys.2022.862212] [Reference Citation Analysis]
33 Ding H, Li J, Jiang K, Gao C, Lu L, Zhang H, Chen H, Gao X, Zhou K, Sun Z. Assessing the inflammatory severity of the terminal ileum in Crohn disease using radiomics based on MRI. BMC Med Imaging 2022;22:118. [PMID: 35787255 DOI: 10.1186/s12880-022-00844-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Xiong S, Whitehurst CE, Li L, Heo GS, Lai CW, Jain U, Muegge BD, Espenschied ST, Musich RJ, Chen M, Liu Y, Liu TC, Stappenbeck TS. Reverse translation approach generates a signature of penetrating fibrosis in Crohn's disease that is associated with anti-TNF response. Gut 2022;71:1289-301. [PMID: 34261752 DOI: 10.1136/gutjnl-2020-323405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kataria J, Kerr J, Lourenssen SR, Blennerhassett MG. Nintedanib regulates intestinal smooth muscle hyperplasia and phenotype in vitro and in TNBS colitis in vivo. Sci Rep 2022;12:10275. [PMID: 35715562 DOI: 10.1038/s41598-022-14491-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Hu S, Bourgonje AR, Gacesa R, Jansen BH, Björk JR, Bangma A, Hidding IJ, van Dullemen HM, Visschedijk MC, Faber KN, Dijkstra G, Harmsen HJM, Festen EAM, Vila AV, Spekhorst LM, Weersma RK. Mucosal host–microbe interactions associate with clinical phenotypes in inflammatory bowel disease.. [DOI: 10.1101/2022.06.04.494807] [Reference Citation Analysis]
37 Xie M, Xiong Z, Yin S, Xiong J, Li X, Jin L, Zhang F, Chen H, Lan P, Lian L. Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation. Dig Dis Sci 2022;67:2232-43. [PMID: 34009553 DOI: 10.1007/s10620-021-07015-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Meng J, Luo Z, Chen Z, Zhou J, Chen Z, Lu B, Zhang M, Wang Y, Yuan C, Shen X, Huang Q, Zhang Z, Ye Z, Cao Q, Zhou Z, Xu Y, Mao R, Chen M, Sun C, Li Z, Feng ST, Meng X, Huang B, Li X. Intestinal fibrosis classification in patients with Crohn's disease using CT enterography-based deep learning: comparisons with radiomics and radiologists. Eur Radiol 2022. [PMID: 35616733 DOI: 10.1007/s00330-022-08842-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Wang Y, Wang Z, Yang H, Chen S, Zheng D, Liu X, Jiang Q, Chen Y. Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling. Front Pharmacol 2022;13:887497. [DOI: 10.3389/fphar.2022.887497] [Reference Citation Analysis]
40 Loch FN, Kamphues C, Beyer K, Klauschen F, Schineis C, Weixler B, Lauscher JC, Dorenbeck M, Bayerl C, Reiter R. Diagnostic Accuracy of Magnetic Resonance Enterography for the Evaluation of Active and Fibrotic Inflammation in Crohn’s Disease. Front Surg 2022;9:872596. [DOI: 10.3389/fsurg.2022.872596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Steiner CA, Rieder F. No Longer Stretching Credibility: Mechanical Force Meets Inflammation in Experimental Intestinal Stenosis. Dig Dis Sci 2022;67:1702-3. [PMID: 34350517 DOI: 10.1007/s10620-021-07170-4] [Reference Citation Analysis]
42 Steiner CA, Rieder F. No Longer Stretching Credibility: Mechanical Force Meets Inflammation in Experimental Intestinal Stenosis. Dig Dis Sci 2022;67:1702-3. [PMID: 34350517 DOI: 10.1007/s10620-021-07170-4] [Reference Citation Analysis]
43 Fousekis FS, Mitselos IV, Tepelenis K, Pappas-gogos G, Katsanos KH, Lianos GD, Frattini F, Vlachos K, Christodoulou DK. Medical, Endoscopic and Surgical Management of Stricturing Crohn’s Disease: Current Clinical Practice. JCM 2022;11:2366. [DOI: 10.3390/jcm11092366] [Reference Citation Analysis]
44 Chandrasinghe P. Surgical Management of Small Bowel Crohn's Disease. Front Surg 2022;9:759668. [DOI: 10.3389/fsurg.2022.759668] [Reference Citation Analysis]
45 Loras C, Mañosa M, Andújar X, Sánchiz V, Martí-gallostra M, Zabana Y, Gutiérrez A, Barreiro-de Acosta M. Position Statement. Recommendations of the Spanish Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on the treatment of strictures in Crohn’s disease. Gastroenterología y Hepatología (English Edition) 2022;45:315-334. [DOI: 10.1016/j.gastre.2022.04.002] [Reference Citation Analysis]
46 Steiner CA, Berinstein JA, Louissaint J, Higgins PDR, Spence JR, Shannon C, Lu C, Stidham RW, Fletcher JG, Bruining DH, Feagan BG, Jairath V, Baker ME, Bettenworth D, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn's Disease: A Systematic Review. Clin Gastroenterol Hepatol 2022;20:817-846.e10. [PMID: 34089850 DOI: 10.1016/j.cgh.2021.05.054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
47 Lamb CA, Saifuddin A, Powell N, Rieder F. The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease. Gastroenterology 2022;162:1525-42. [PMID: 34995532 DOI: 10.1053/j.gastro.2021.09.077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
48 Vieujean S, Loly JP, Boutaffala L, Meunier P, Reenaers C, Briquet A, Lechanteur C, Baudoux E, Beguin Y, Louis E. Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: A Phase I-II Clinical Study. J Crohns Colitis 2022;16:506-10. [PMID: 34473270 DOI: 10.1093/ecco-jcc/jjab154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Gordon IO, Bettenworth D, Bokemeyer A, Srivastava A, Rosty C, de Hertogh G, Robert ME, Valasek MA, Mao R, Li J, Harpaz N, Borralho P, Pai RK, Odze R, Feakins R, Parker CE, Guizzetti L, Nguyen T, Shackelton LM, Sandborn WJ, Jairath V, Baker M, Bruining D, Fletcher JG, Feagan BG, Pai RK, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. International consensus to standardise histopathological scoring for small bowel strictures in Crohn's disease. Gut 2022;71:479-86. [PMID: 33952604 DOI: 10.1136/gutjnl-2021-324374] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
50 D'Alessio S, Ungaro F, Noviello D, Lovisa S, Peyrin-Biroulet L, Danese S. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat Rev Gastroenterol Hepatol 2022;19:169-84. [PMID: 34876680 DOI: 10.1038/s41575-021-00543-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
51 Ismail MS, Charabaty A. Management of Crohn’s stricture: medical, endoscopic and surgical therapies. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2021-101827] [Reference Citation Analysis]
52 Danilov MA, Leontiev AV, Abdulatipova ZM, Demidova AA. [Strictureplasty or resection? Optimal approach for fibrostenotic Crohn's disease]. Khirurgiia (Mosk) 2022;:100-3. [PMID: 35147008 DOI: 10.17116/hirurgia2022021100] [Reference Citation Analysis]
53 Hayashi Y, Nakase H. The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease. Front Physiol 2022;13:845078. [DOI: 10.3389/fphys.2022.845078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Ueno A, Jijon HB, Peng R, Sparksman S, Mainoli B, Filyk A, Li Y, Wilson S, Novak K, Panaccione R, Hirota S, Dufour A, Lu C, Beck PL. Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease. Inflamm Bowel Dis 2022;28:246-58. [PMID: 34428284 DOI: 10.1093/ibd/izab157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Huang M, Jiang W, Luo C, Yang M, Ren Y. Atractylenolide III inhibits epithelial‑mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway. Mol Med Rep 2022;25:98. [PMID: 35088892 DOI: 10.3892/mmr.2022.12614] [Reference Citation Analysis]
56 Santacroce G, Lenti MV, Di Sabatino A. Therapeutic Targeting of Intestinal Fibrosis in Crohn's Disease. Cells 2022;11:429. [PMID: 35159238 DOI: 10.3390/cells11030429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
57 Bushara O, Escobar DJ, Weinberg SE, Sun L, Liao J, Yang GY. The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn's Disease. Pathobiology 2022;:1-11. [PMID: 35026755 DOI: 10.1159/000521259] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wang M, Zhou B, Cong W, Zhang M, Li Z, Li Y, Liang S, Chen K, Yang D, Wu Z. Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis. Front Pharmacol 2021;12:797605. [PMID: 35002731 DOI: 10.3389/fphar.2021.797605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Qiao L, Fang L, Zhu J, Xiang Y, Xu H, Sun X, Chen H, Yang B. Total Flavone of Abelmoschus manihot Ameliorates TNBS-Induced Colonic Fibrosis by Regulating Th17/Treg Balance and Reducing Extracellular Matrix. Front Pharmacol 2021;12:769793. [PMID: 35002710 DOI: 10.3389/fphar.2021.769793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
60 Shi X. Mechano-Regulation of Gene Expression in the Gut: Implications in Pathophysiology and Therapeutic Approaches in Obstructive, Inflammatory, and Functional Bowel Disorders. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00168-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ismail MS, Akshintala VS, Kumbhari V, Selaru FM. Impedance Planimetry for Crohn's Disease Anastomotic Stricture Characterization: A Predictor of Treatment Response? ACG Case Rep J 2022;9:e00729. [DOI: 10.14309/crj.0000000000000729] [Reference Citation Analysis]
62 Jasso GJ, Jaiswal A, Varma M, Laszewski T, Grauel A, Omar A, Silva N, Dranoff G, Porter JA, Mansfield K, Cremasco V, Regev A, Xavier RJ, Graham DB. Colon stroma mediates an inflammation-driven fibroblastic response controlling matrix remodeling and healing. PLoS Biol 2022;20:e3001532. [PMID: 35085231 DOI: 10.1371/journal.pbio.3001532] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
63 Mazza S, Conforti FS, Forzenigo LV, Piazza N, Bertè R, Costantino A, Fraquelli M, Coletta M, Rimola J, Vecchi M, Caprioli F. Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease. Dig Liver Dis 2022;54:69-75. [PMID: 34116973 DOI: 10.1016/j.dld.2021.05.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 D'Haens G, Rieder F, Feagan BG, Higgins PDR, Panés J, Maaser C, Rogler G, Löwenberg M, van der Voort R, Pinzani M, Peyrin-Biroulet L, Danese S; International Organization for Inflammatory Bowel Disease Fibrosis Working Group. Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease. Gastroenterology 2022;162:26-31. [PMID: 31254502 DOI: 10.1053/j.gastro.2019.05.072] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
65 Goren I, Rieder F. Endoscopic interventions for stricturing Crohn's disease. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(21)00429-5] [Reference Citation Analysis]
66 Tandon P, Weizman AV. Management of the Hospitalized Patient with Inflammatory and Stricturing Crohn’s Disease. Management of Inpatient Inflammatory Bowel Disease 2022. [DOI: 10.1007/978-1-0716-1987-2_5] [Reference Citation Analysis]
67 Loras C, Andújar X, Gornals JB, Sanchiz V, Brullet E, Sicilia B, Martín-arranz MD, Naranjo A, Barrio J, Dueñas C, Foruny JR, Busquets D, Monfort D, Pineda JR, González-huix F, Pérez-roldán F, Pons V, González B, Reyes Moreno J, Sainz E, Guardiola J, Bosca-watts MM, Fernández-bañares F, Mayor V, Esteve M. Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn's disease (ProtDilat study): an open-label, multicentre, randomised trial. The Lancet Gastroenterology & Hepatology 2022. [DOI: 10.1016/s2468-1253(21)00386-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
68 Xie H, Jiao Y, Zhou X, Liao X, Chen J, Chen H, Chen L, Yu S, Deng Q, Sun L, Xu X, Wang J. Integrin αvβ6 contributes to the development of intestinal fibrosis via the FAK/AKT signaling pathway. Exp Cell Res 2021;411:113003. [PMID: 34979108 DOI: 10.1016/j.yexcr.2021.113003] [Reference Citation Analysis]
69 Dehghan M, Wong G, Neuberger E, Kin C, Rieder F, Park KT. Worse outcomes and higher costs of care in fibrostenotic Crohn's disease: a real-world propensity-matched analysis in the USA. BMJ Open Gastroenterol 2021;8:e000781. [PMID: 34930755 DOI: 10.1136/bmjgast-2021-000781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Geesala R, Lin YM, Zhang K, Shi XZ. Targeting Mechano-Transcription Process as Therapeutic Intervention in Gastrointestinal Disorders. Front Pharmacol 2021;12:809350. [PMID: 34992543 DOI: 10.3389/fphar.2021.809350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Estrada HQ, Patel S, Rabizadeh S, Casero D, Targan SR, Barrett RJ. Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells. Inflamm Bowel Dis 2022;28:667-79. [PMID: 34918082 DOI: 10.1093/ibd/izab292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Honzawa Y, Yamamoto S, Okabe M, Seno H, Nakase H. Current Topics of the Mechanism of Intestinal Fibrosis in Crohn’s Disease. Immuno 2021;1:574-82. [DOI: 10.3390/immuno1040040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Zhao Y, Ma T, Zou D. Identification of Unique Transcriptomic Signatures and Hub Genes Through RNA Sequencing and Integrated WGCNA and PPI Network Analysis in Nonerosive Reflux Disease. J Inflamm Res 2021;14:6143-56. [PMID: 34848992 DOI: 10.2147/JIR.S340452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
74 Kondo A, Ma S, Lee MYY, Ortiz V, Traum D, Schug J, Wilkins B, Terry NA, Lee H, Kaestner KH. Highly Multiplexed Image Analysis of Intestinal Tissue Sections in Patients With Inflammatory Bowel Disease. Gastroenterology 2021;161:1940-52. [PMID: 34529988 DOI: 10.1053/j.gastro.2021.08.055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
75 Zhao M, Weng Z, Huang Y, Zheng H, Han D, Shen J, Huang R, Liu H, Wu L. Herb-Partitioned Moxibustion Improves Crohn's Disease-Associated Intestinal Fibrosis by Suppressing the RhoA/ROCK1/MLC Pathway. Evid Based Complement Alternat Med 2021;2021:2247953. [PMID: 34840583 DOI: 10.1155/2021/2247953] [Reference Citation Analysis]
76 Wan J, Yuan XQ, Wu TQ, Yang MQ, Wu XC, Gao RY, Yin L, Chen CQ. Laparoscopic vs open surgery in ileostomy reversal in Crohn’s disease: A retrospective study. World J Gastrointest Surg 2021; 13(11): 1414-1422 [DOI: 10.4240/wjgs.v13.i11.1414] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Chen H, Han T, Gao L, Zhang D. The Involvement of Glial Cell-Derived Neurotrophic Factor in Inflammatory Bowel Disease. J Interferon Cytokine Res 2021. [PMID: 34846920 DOI: 10.1089/jir.2021.0116] [Reference Citation Analysis]
78 Lis-López L, Bauset C, Seco-Cervera M, Cosín-Roger J. Is the Macrophage Phenotype Determinant for Fibrosis Development? Biomedicines 2021;9:1747. [PMID: 34944564 DOI: 10.3390/biomedicines9121747] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
79 Jacobs I, Ceulemans M, Wauters L, Breynaert C, Vermeire S, Verstockt B, Vanuytsel T. Role of Eosinophils in Intestinal Inflammation and Fibrosis in Inflammatory Bowel Disease: An Overlooked Villain? Front Immunol 2021;12:754413. [PMID: 34737752 DOI: 10.3389/fimmu.2021.754413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
80 Martins KR, Araújo JM, Cruz ÁC, Luiz-Ferreira A. EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE WESTERN REGION OF MINAS GERAIS STATE. Arq Gastroenterol 2021;58:377-83. [PMID: 34705974 DOI: 10.1590/S0004-2803.202100000-63] [Reference Citation Analysis]
81 Bali A, Rani M. Recent Advances in Diagnosis and Management of Crohn’s Disease. Crohn’s Disease Recent Advances 2021. [DOI: 10.5772/intechopen.97693] [Reference Citation Analysis]
82 Golusda L, Kühl AA, Siegmund B, Paclik D. Extracellular Matrix Components as Diagnostic Tools in Inflammatory Bowel Disease. Biology 2021;10:1024. [DOI: 10.3390/biology10101024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Vieujean S, Hu S, Bequet E, Salee C, Massot C, Bletard N, Pierre N, Quesada Calvo F, Baiwir D, Mazzucchelli G, De Pauw E, Coimbra Marques C, Delvenne P, Rieder F, Louis E, Meuwis MA. Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis. J Crohns Colitis 2021;15:1737-50. [PMID: 33822017 DOI: 10.1093/ecco-jcc/jjab061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
84 Fumery M, Yzet C, Chatelain D, Yzet T, Brazier F, LeMouel JP, Laharie D, Sabbagh C. Colonic Strictures in Inflammatory Bowel Disease: Epidemiology, Complications, and Management. J Crohns Colitis 2021;15:1766-73. [PMID: 33844013 DOI: 10.1093/ecco-jcc/jjab068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
85 Fujita M, Suzuki H, Fukai F. Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression. World J Gastrointest Oncol 2021; 13(9): 980-994 [PMID: 34616507 DOI: 10.4251/wjgo.v13.i9.980] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Marion-Letellier R, Leboutte M, Amamou A, Raman M, Savoye G, Ghosh S. Diet in Intestinal Fibrosis: A Double-Edged Sword. Nutrients 2021;13:3148. [PMID: 34579023 DOI: 10.3390/nu13093148] [Reference Citation Analysis]
87 Elias M, Zhao S, Le HT, Wang J, Neurath MF, Neufert C, Fiocchi C, Rieder F. IL-36 in chronic inflammation and fibrosis - bridging the gap? J Clin Invest 2021;131:144336. [PMID: 33463541 DOI: 10.1172/JCI144336] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
88 Ślósarz D, Poniewierka E, Neubauer K, Kempiński R. Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease-Systematic Review. J Clin Med 2021;10:4044. [PMID: 34575156 DOI: 10.3390/jcm10184044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
89 Wang R, Wang D, Wang H, Wang T, Weng Y, Zhang Y, Luo Y, Lu Y, Wang Y. Therapeutic Targeting of Nrf2 Signaling by Maggot Extracts Ameliorates Inflammation-Associated Intestinal Fibrosis in Chronic DSS-Induced Colitis. Front Immunol 2021;12:670159. [PMID: 34456904 DOI: 10.3389/fimmu.2021.670159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
90 Lu B, Lin J, Du J, He S, Cao Q, Huang L, Mao R, Sun C, Li Z, Feng S, Li X. Native T1 Mapping and Magnetization Transfer Imaging in Grading Bowel Fibrosis in Crohn's Disease: A Comparative Animal Study. Biosensors (Basel) 2021;11:302. [PMID: 34562892 DOI: 10.3390/bios11090302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Huang H, Liu B, Qu N, Zhang S, Bai X, Handley M, Shan F. Research progress of opioid growth factor in immune-related diseases and cancer diseases. Int Immunopharmacol 2021;99:107713. [PMID: 34426103 DOI: 10.1016/j.intimp.2021.107713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Nicoletti F, Hammer L, Furtado S, Mangano K, Mathiowitz E, Green B, Auci DL. Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis. Inflamm Bowel Dis 2022;28:455-65. [PMID: 34417826 DOI: 10.1093/ibd/izab204] [Reference Citation Analysis]
93 Gough NR, Xiang X, Mishra L. TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer. Gastroenterology 2021;161:434-452.e15. [PMID: 33940008 DOI: 10.1053/j.gastro.2021.04.064] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 15.5] [Reference Citation Analysis]
94 Kuznietsova H, Ogloblya O. Therapy that Targets Growth Factor Receptors: Novel Approach for Liver Cirrhosis Treatment. Advances in Hepatology 2021. [DOI: 10.5772/intechopen.96552] [Reference Citation Analysis]
95 Sivasailam B, Manski S, Wentz A, Cross RK. Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation. Inflamm Bowel Dis 2021;27:1230-6. [PMID: 33165536 DOI: 10.1093/ibd/izaa276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Caparrós E, Wiest R, Scharl M, Rogler G, Gutiérrez Casbas A, Yilmaz B, Wawrzyniak M, Francés R. Dysbiotic microbiota interactions in Crohn's disease. Gut Microbes 2021;13:1949096. [PMID: 34313550 DOI: 10.1080/19490976.2021.1949096] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
97 Kandilogiannakis L, Filidou E, Drygiannakis I, Tarapatzi G, Didaskalou S, Koffa M, Arvanitidis K, Bamias G, Valatas V, Paspaliaris V, Kolios G. Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and Fibrosis. Stem Cells Int 2021;2021:9929461. [PMID: 34354753 DOI: 10.1155/2021/9929461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
98 Johnson LA, Rodansky ES, Tran A, Collins SG, Eaton KA, Malamet B, Steiner CA, Huang S, Spence JR, Higgins PDR. Effect of ABT-263 on Intestinal Fibrosis in Human Myofibroblasts, Human Intestinal Organoids, and the Mouse Salmonella typhimurium Model. Inflamm Bowel Dis 2022;28:161-75. [PMID: 34302470 DOI: 10.1093/ibd/izab166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Amamou A, Rouland M, Yaker L, Goichon A, Guérin C, Aziz M, Savoye G, Marion-Letellier R. Dietary salt exacerbates intestinal fibrosis in chronic TNBS colitis via fibroblasts activation. Sci Rep 2021;11:15055. [PMID: 34301970 DOI: 10.1038/s41598-021-94280-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
100 Ford MM. Crohn's Disease Obstructions. Clin Colon Rectal Surg 2021;34:227-32. [PMID: 34305471 DOI: 10.1055/s-0041-1729926] [Reference Citation Analysis]
101 Zhan S, Li N, Liu C, Mao R, Wu D, Li T, Chen M, Zhuang X, Zeng Z. Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs. Front Microbiol 2021;12:694967. [PMID: 34335525 DOI: 10.3389/fmicb.2021.694967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
102 Loras C, Mañosa M, Andújar X, Sánchiz V, Martí-Gallostra M, Zabana Y, Gutiérrez A, Barreiro-de Acosta M; en representación de GETECCU. Position Statement. Recommendations of the Spanish Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of strictures in Crohn's disease. Gastroenterol Hepatol 2021:S0210-5705(21)00219-3. [PMID: 34274357 DOI: 10.1016/j.gastrohep.2021.07.001] [Reference Citation Analysis]
103 Iwata K, Mikami Y, Kato M, Yahagi N, Kanai T. Pathogenesis and management of gastrointestinal inflammation and fibrosis: from inflammatory bowel diseases to endoscopic surgery. Inflamm Regen 2021;41:21. [PMID: 34261521 DOI: 10.1186/s41232-021-00174-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Prados ME, García-Martín A, Unciti-Broceta JD, Palomares B, Collado JA, Minassi A, Calzado MA, Appendino G, Muñoz E. Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease. Acta Pharmacol Sin 2021;42:1124-38. [PMID: 32811965 DOI: 10.1038/s41401-020-0497-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
105 Wenxiu J, Mingyue Y, Fei H, Yuxin L, Mengyao W, Chenyang L, Jia S, Hong Z, Shih DQ, Targan SR, Xiaolan Z. Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis. Mediators Inflamm 2021;2021:5927064. [PMID: 34257516 DOI: 10.1155/2021/5927064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
106 Agista AZ, Rusbana TB, Islam J, Ohsaki Y, Sultana H, Hirakawa R, Watanabe K, Nochi T, Ardiansyah, Budijanto S, Yang SC, Koseki T, Aso H, Komai M, Shirakawa H. Fermented Rice Bran Supplementation Prevents the Development of Intestinal Fibrosis Due to DSS-Induced Inflammation in Mice. Nutrients 2021;13:1869. [PMID: 34070845 DOI: 10.3390/nu13061869] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
107 Budi EH, Schaub JR, Decaris M, Turner S, Derynck R. TGF-β as a driver of fibrosis: physiological roles and therapeutic opportunities. J Pathol 2021;254:358-73. [PMID: 33834494 DOI: 10.1002/path.5680] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
108 Castro-Dopico T, Fleming A, Dennison TW, Ferdinand JR, Harcourt K, Stewart BJ, Cader Z, Tuong ZK, Jing C, Lok LSC, Mathews RJ, Portet A, Kaser A, Clare S, Clatworthy MR. GM-CSF Calibrates Macrophage Defense and Wound Healing Programs during Intestinal Infection and Inflammation. Cell Rep 2020;32:107857. [PMID: 32640223 DOI: 10.1016/j.celrep.2020.107857] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 18.5] [Reference Citation Analysis]
109 Ferretti F, Cannatelli R, Ardizzone S, Maier JA, Maconi G. Ultrasonographic Evaluation of Intestinal Fibrosis and Inflammation in Crohn's Disease. The State of the Art. Front Pharmacol 2021;12:679924. [PMID: 33981246 DOI: 10.3389/fphar.2021.679924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
110 Bai B, Wu F, Ying K, Xu Y, Shan L, Lv Y, Gao X, Xu D, Lu J, Xie B. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer. Theranostics 2021;11:6225-39. [PMID: 33995655 DOI: 10.7150/thno.55939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
111 Tavares de Sousa H, Gullo I, Castelli C, Dias CC, Rieder F, Carneiro F, Magro F. Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype. Clin Transl Gastroenterol 2021;12:e00330. [PMID: 33848279 DOI: 10.14309/ctg.0000000000000330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
112 Li N, Ouyang Y, Xu X, Yuan Z, Liu C, Zhu Z. MiR-155 promotes colitis-associated intestinal fibrosis by targeting HBP1/Wnt/β-catenin signalling pathway. J Cell Mol Med 2021;25:4765-75. [PMID: 33769664 DOI: 10.1111/jcmm.16445] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
113 Han X, Ding S, Jiang H, Liu G. Roles of Macrophages in the Development and Treatment of Gut Inflammation. Front Cell Dev Biol 2021;9:625423. [PMID: 33738283 DOI: 10.3389/fcell.2021.625423] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
114 Leon G, Hussey S, Walsh PT. The Diverse Roles of the IL-36 Family in Gastrointestinal Inflammation and Resolution. Inflamm Bowel Dis 2021;27:440-50. [PMID: 32860042 DOI: 10.1093/ibd/izaa232] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
115 Grajo JR, Huang C, Dillman JR, Gee MS, Jaffe TA, Soto JA, Baker ME. MR Enterography of Complicated Crohn Disease: Stricturing and Penetrating Disease. Top Magn Reson Imaging 2021;30:23-30. [PMID: 33528209 DOI: 10.1097/RMR.0000000000000266] [Reference Citation Analysis]
116 Muñoz F, Ripollés T, Poza Cordón J, de las Heras Páez de la Cadena B, Martínez-pérez MJ, de Miguel E, Zabana Y, Mañosa Ciria M, Beltrán B, Barreiro-de Acosta M. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of abdominal ultrasound in inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 2021;44:158-174. [DOI: 10.1016/j.gastre.2020.05.018] [Reference Citation Analysis]
117 Konstantinidis AO, Adamama-Moraitou KK, Pardali D, Dovas CI, Brellou GD, Papadopoulos T, Jergens AE, Allenspach K, Rallis TS. Colonic mucosal and cytobrush sample cytokine mRNA expression in canine inflammatory bowel disease and their correlation with disease activity, endoscopic and histopathologic score. PLoS One 2021;16:e0245713. [PMID: 33471872 DOI: 10.1371/journal.pone.0245713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Mao R, Doyon G, Gordon IO, Li J, Lin S, Wang J, Le THN, Elias M, Kurada S, Southern B, Olman M, Chen M, Zhao S, Dejanovic D, Chandra J, Mukherjee PK, West G, Van Wagoner DR, Fiocchi C, Rieder F. Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn's disease. Gut 2022;71:55-67. [PMID: 33468536 DOI: 10.1136/gutjnl-2020-323719] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
119 Marin AM, Calapod OP, Moldoveanu AC, Tribus LC, Fierbințeanu-Braticevici C. Non-invasive Ultrasonographic Score for Assessment of the Severity of Inflammatory Bowel Disease. Ultrasound Med Biol 2021;47:932-40. [PMID: 33388210 DOI: 10.1016/j.ultrasmedbio.2020.11.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
120 Sleiman J, El Ouali S, Qazi T, Cohen B, Steele SR, Baker ME, Rieder F. Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges. Expert Rev Gastroenterol Hepatol 2021;15:401-11. [PMID: 33225766 DOI: 10.1080/17474124.2021.1854732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
121 Zhou LY, Lin SN, Rieder F, Chen MH, Zhang SH, Mao R. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside. Inflamm Bowel Dis 2021;27:971-82. [PMID: 33324986 DOI: 10.1093/ibd/izaa321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
122 Muñoz F, Ripollés T, Poza Cordón J, de Las Heras Páez de la Cadena B, Martínez-Pérez MJ, de Miguel E, Zabana Y, Mañosa Ciria M, Beltrán B, Barreiro-de Acosta M. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of abdominal ultrasound in inflammatory bowel disease. Gastroenterol Hepatol 2021;44:158-74. [PMID: 33309386 DOI: 10.1016/j.gastrohep.2020.05.009] [Reference Citation Analysis]
123 Dupont-Lucas C, Marion-Letellier R, Pala M, Guerin C, Amamou A, Jarbeau M, Bôle-Feysot C, Nicol L, David A, Aziz M, Colasse E, Savoye-Collet C, Savoye G. A polymeric diet rich in transforming growth factor beta 2 does not reduce inflammation in chronic 2,4,6-trinitrobenzene sulfonic acid colitis in pre-pubertal rats. BMC Gastroenterol 2020;20:416. [PMID: 33302890 DOI: 10.1186/s12876-020-01574-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
124 Cui J, Li Y, Jiao C, Gao J, He Y, Nie B, Kong L, Guo W, Xu Q. Improvement of magnesium isoglycyrrhizinate on DSS-induced acute and chronic colitis. Int Immunopharmacol 2021;90:107194. [PMID: 33290965 DOI: 10.1016/j.intimp.2020.107194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
125 Dmochowska N, Tieu W, Keller MD, Hollis CA, Campaniello MA, Mavrangelos C, Takhar P, Hughes PA. 89Zr-pro-MMP-9 F(ab')2 detects colitis induced intestinal and kidney fibrosis. Sci Rep 2020;10:20372. [PMID: 33230169 DOI: 10.1038/s41598-020-77390-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
126 Shivaji UN, Evans M, Critchlow T, Gui X, Smith SCL, Pinkney T, Iacucci M, Cooney R, Ghosh S, Skordilis K. Chronic inflammation and other changes are significant components of clinically fibrotic strictures in Crohn's disease: a histological study of resected strictures clinically characterized as noninflamed. Eur J Gastroenterol Hepatol 2020;32:1432-9. [PMID: 32639416 DOI: 10.1097/MEG.0000000000001796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Bettenworth D, Bokemeyer A, Kou L, Lopez R, Bena JF, El Ouali S, Mao R, Kurada S, Bhatt A, Beyna T, Halloran B, Reeson M, Hosomi S, Kishi M, Hirai F, Ohmiya N, Rieder F. Systematic review with meta-analysis: efficacy of balloon-assisted enteroscopy for dilation of small bowel Crohn's disease strictures. Aliment Pharmacol Ther 2020;52:1104-16. [PMID: 32813282 DOI: 10.1111/apt.16049] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
128 Gundersen MD, Goll R, Fenton CG, Anderssen E, Sørbye SW, Florholmen JR, Paulssen RH. Fibrosis Mediators in the Colonic Mucosa of Acute and Healed Ulcerative Colitis. Clin Transl Gastroenterol 2019;10:e00082. [PMID: 31584460 DOI: 10.14309/ctg.0000000000000082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
129 Subramanian S, Du C, Tan XD. Can Rodent Model of Acetic Acid-Induced Colitis be Used to Study the Pathogenesis of Colitis-Associated Intestinal Fibrosis? J Invest Surg 2020;:1-2. [PMID: 32951484 DOI: 10.1080/08941939.2020.1821845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Melton E, Qiu H. Interleukin-36 Cytokine/Receptor Signaling: A New Target for Tissue Fibrosis. Int J Mol Sci 2020;21:E6458. [PMID: 32899668 DOI: 10.3390/ijms21186458] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
131 van Haaften WT, Blokzijl T, Hofker HS, Olinga P, Dijkstra G, Bank RA, Boersema M. Intestinal stenosis in Crohn's disease shows a generalized upregulation of genes involved in collagen metabolism and recognition that could serve as novel anti-fibrotic drug targets. Therap Adv Gastroenterol 2020;13:1756284820952578. [PMID: 32922514 DOI: 10.1177/1756284820952578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
132 Le Fur M, Zhou IY, Catalano O, Caravan P. Toward Molecular Imaging of Intestinal Pathology. Inflamm Bowel Dis 2020;26:1470-84. [PMID: 32793946 DOI: 10.1093/ibd/izaa213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Rodríguez-Lago I, Hoyo JD, Pérez-Girbés A, Garrido-Marín A, Casanova MJ, Chaparro M, Fernández-Clotet A, Castro-Poceiro J, García MJ, Sánchez S, Ferreiro-Iglesias R, Bastón I, Piqueras M, Careda LEIB, Mena R, Suárez C, Cordón JP, López-García A, Márquez L, Arroyo M, Alfambra E, Sierra M, Cano N, Delgado-Guillena P, Morales-Alvarado V, Aparicio JC, Guerra I, Aulló C, Merino O, Arranz L, Hidalgo MA, Llaó J, Plaza R, Molina G, Torres P, Pérez-Galindo P, Romero MG, Herrera-deGuise C, Armesto E, Mesonero F, Frago-Larramona S, Benítez JM, Calvo M, Martín MDCL, Elorza A, Larena A, Peña E, Rodríguez-Grau MDC, Miguel-Criado J, Botella B, Olmos JA, López L, Aguirre U, Gisbert JP; Young GETECCU Group. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease. United European Gastroenterol J 2020;8:1056-66. [PMID: 32723069 DOI: 10.1177/2050640620947579] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
134 Yang SB, Du SW, Wang JH. Correlation between age of onset and gastrointestinal stenosis in hospitalized patients with Crohn's disease. World J Clin Cases 2020; 8(13): 2769-2777 [PMID: 32742987 DOI: 10.12998/wjcc.v8.i13.2769] [Reference Citation Analysis]
135 Crespi M, Dulbecco P, De Ceglie A, Conio M. Strictures in Crohn's Disease: From Pathophysiology to Treatment. Dig Dis Sci 2020;65:1904-16. [PMID: 32279173 DOI: 10.1007/s10620-020-06227-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
136 Pershko AM, Grinevich VB, Solovyov IA, Kurilo DP. Modern strategies of therapeutic and surgical treatment of Crohn’s disease. jour 2020;174:89-95. [DOI: 10.31146/1682-8658-ecg-176-4-89-95] [Reference Citation Analysis]
137 Creyns B, Cremer J, De Hertogh G, Boon L, Ferrante M, Vermeire S, Van Assche G, Ceuppens JL, Breynaert C. Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells. Immun Inflamm Dis 2020;8:393-407. [PMID: 32567222 DOI: 10.1002/iid3.321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
138 Li C, Grider JR, Murthy KS, Bohl J, Rivet E, Wieghard N, Kuemmerle JF. Endoplasmic Reticulum Stress in Subepithelial Myofibroblasts Increases the TGF-β1 Activity That Regulates Fibrosis in Crohn's Disease. Inflamm Bowel Dis 2020;26:809-19. [PMID: 32031621 DOI: 10.1093/ibd/izaa015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
139 Zhao JF, Ling FM, Li JR, Chen YD, Huang L, Zhu LR. Role of non-inflammatory factors in intestinal fibrosis. J Dig Dis 2020;21:315-8. [PMID: 32406603 DOI: 10.1111/1751-2980.12883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
140 Zhong YK, Lu BL, Huang SY, Chen YJ, Li ZP, Rimola J, Li XH. Cross-sectional imaging for assessing intestinal fibrosis in Crohn's disease. J Dig Dis 2020;21:342-50. [PMID: 32418328 DOI: 10.1111/1751-2980.12881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
141 Li C, Kuemmerle JF. The fate of myofibroblasts during the development of fibrosis in Crohn's disease. J Dig Dis 2020;21:326-31. [PMID: 32092217 DOI: 10.1111/1751-2980.12852] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
142 Gu YB, Zhong J; Chinese IBD Endoscopic Club. Endoscopic management of stricturing Crohn's disease. J Dig Dis 2020;21:351-4. [PMID: 32537911 DOI: 10.1111/1751-2980.12914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Mao R, Rimola J, Chen MH, Rieder F. Intestinal fibrosis: The Achilles heel of inflammatory bowel diseases? J Dig Dis 2020;21:306-7. [PMID: 32407586 DOI: 10.1111/1751-2980.12876] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
144 Chervy M, Barnich N, Denizot J. Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn's Disease. Int J Mol Sci 2020;21:E3734. [PMID: 32466328 DOI: 10.3390/ijms21103734] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
145 Leppkes M, Neurath MF. Cytokines in inflammatory bowel diseases - Update 2020. Pharmacol Res 2020;158:104835. [PMID: 32416212 DOI: 10.1016/j.phrs.2020.104835] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 15.7] [Reference Citation Analysis]
146 Latella G, Viscido A. Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis. Dig Dis Sci 2020;65:1299-306. [PMID: 32124197 DOI: 10.1007/s10620-020-06161-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
147 Stidham RW, Enchakalody B, Waljee AK, Higgins PDR, Wang SC, Su GL, Wasnik AP, Al-Hawary M. Assessing Small Bowel Stricturing and Morphology in Crohn's Disease Using Semi-automated Image Analysis. Inflamm Bowel Dis 2020;26:734-42. [PMID: 31504540 DOI: 10.1093/ibd/izz196] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
148 Ortiz-Masiá D, Gisbert-Ferrándiz L, Bauset C, Coll S, Mamie C, Scharl M, Esplugues JV, Alós R, Navarro F, Cosín-Roger J, Barrachina MD, Calatayud S. Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development. Cells 2020;9:E1104. [PMID: 32365557 DOI: 10.3390/cells9051104] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
149 Rowe JC, Huang AA, Heo J, Parnell NK, Rudinsky AJ. Benign Duodenal Stricture Treated with Surgical Correction and Dietary Therapy in a Golden Retriever. Case Rep Vet Med 2020;2020:4283175. [PMID: 32318308 DOI: 10.1155/2020/4283175] [Reference Citation Analysis]
150 Rimola J, Capozzi N. Differentiation of fibrotic and inflammatory component of Crohn's disease-associated strictures. Intest Res 2020;18:144-50. [PMID: 32326668 DOI: 10.5217/ir.2020.00015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
151 Lin S, Lin X, Li X, Chen M, Mao R. Making Qualitative Intestinal Stricture Quantitative: Embracing Radiomics in IBD. Inflamm Bowel Dis 2020;26:743-5. [PMID: 31504502 DOI: 10.1093/ibd/izz197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
152 Yoo JH, Holubar S, Rieder F. Fibrostenotic strictures in Crohn's disease. Intest Res 2020;18:379-401. [PMID: 32259917 DOI: 10.5217/ir.2019.09148] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
153 Gao J, Cui J, Zhong H, Li Y, Liu W, Jiao C, Gao J, Jiang C, Guo W, Xu Q. Andrographolide sulfonate ameliorates chronic colitis induced by TNBS in mice via decreasing inflammation and fibrosis. Int Immunopharmacol 2020;83:106426. [PMID: 32220806 DOI: 10.1016/j.intimp.2020.106426] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
154 Caër C, Wick MJ. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease. Front Immunol 2020;11:410. [PMID: 32256490 DOI: 10.3389/fimmu.2020.00410] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
155 Imai J, Yahata T, Ichikawa H, Ibrahim AA, Yazawa M, Sumiyoshi H, Inagaki Y, Matsushima M, Suzuki T, Mine T, Ando K, Miyata T, Hozumi K. Inhibition of plasminogen activator inhibitor-1 attenuates against intestinal fibrosis in mice. Intest Res 2020;18:219-28. [PMID: 32050315 DOI: 10.5217/ir.2019.00037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
156 Butt WT, Ryan ÉJ, Boland MR, Mccarthy EM, Omorogbe J, Hazel K, Bass GA, Neary PC, Kavanagh DO, Mcnamara D, O’riordan JM. Strictureplasty versus bowel resection for the surgical management of fibrostenotic Crohn’s disease: a systematic review and meta-analysis. Int J Colorectal Dis 2020;35:705-17. [DOI: 10.1007/s00384-020-03507-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
157 Zhao S, Dejanovic D, Yao P, Bhilocha S, Sadler T, Schirbel A, West G, Doyon G, Lopez R, Mao R, Kurada S, El Ouali S, Grassl G, Fox PL, Cruise M, Worthley DL, de la Motte C, Fiocchi C, Rieder F. Selective deletion of MyD88 signaling in α-SMA positive cells ameliorates experimental intestinal fibrosis via post-transcriptional regulation. Mucosal Immunol 2020;13:665-78. [PMID: 32020030 DOI: 10.1038/s41385-020-0259-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
158 Rimola J, Capozzi N. Magnetic Resonance in Crohn Disease. Magnetic Resonance Imaging Clinics of North America 2020;28:45-53. [DOI: 10.1016/j.mric.2019.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
159 Lu X, Xie S, Ye L, Zhu L, Yu Q. Lactobacillus Protects Against S. Typhimurium-Induced Intestinal Inflammation by Determining the Fate of Epithelial Proliferation and Differentiation. Mol Nutr Food Res 2020;64:e1900655. [PMID: 31953989 DOI: 10.1002/mnfr.201900655] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
160 Wu F, Shao Q, Hu M, Zhao Y, Dong R, Fang K, Xu L, Zou X, Lu F, Li J, Chen G. Wu-Mei-Wan ameliorates chronic colitis-associated intestinal fibrosis through inhibiting fibroblast activation. J Ethnopharmacol 2020;252:112580. [PMID: 31972322 DOI: 10.1016/j.jep.2020.112580] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
161 El Ouali S, Click B, Holubar SD, Rieder F. Natural history, diagnosis and treatment approach to fibrostenosing Crohn's disease. United European Gastroenterol J 2020;8:263-70. [PMID: 32213020 DOI: 10.1177/2050640620901960] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
162 Cummins CB, Gu Y, Wang X, Lin YM, Shi XZ, Radhakrishnan RS. Burn-Induced Impairment of Ileal Muscle Contractility Is Associated with Increased Extracellular Matrix Components. J Gastrointest Surg 2020;24:188-97. [PMID: 31637625 DOI: 10.1007/s11605-019-04400-z] [Reference Citation Analysis]
163 Gordon IO, Bettenworth D, Bokemeyer A, Srivastava A, Rosty C, de Hertogh G, Robert ME, Valasek MA, Mao R, Kurada S, Harpaz N, Borralho P, Pai RK, Pai RK, Odze R, Feakins R, Parker CE, Nguyen T, Jairath V, Baker ME, Bruining DH, Fletcher JG, Feagan BG, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review. Gastroenterology 2020;158:137-150.e1. [PMID: 31476299 DOI: 10.1053/j.gastro.2019.08.033] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
164 Bokemeyer A, Tepasse PR, Quill L, Lenz P, Rijcken E, Vieth M, Ding N, Ketelhut S, Rieder F, Kemper B, Bettenworth D. Quantitative Phase Imaging Using Digital Holographic Microscopy Reliably Assesses Morphology and Reflects Elastic Properties of Fibrotic Intestinal Tissue. Sci Rep 2019;9:19388. [PMID: 31852983 DOI: 10.1038/s41598-019-56045-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
165 Neufert C, Neurath MF, Atreya R. Rationale for IL-36 receptor antibodies in ulcerative colitis. Expert Opin Biol Ther 2020;20:339-42. [PMID: 31773994 DOI: 10.1080/14712598.2020.1695775] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
166 Thoo L, Noti M, Krebs P. Keep calm: the intestinal barrier at the interface of peace and war. Cell Death Dis 2019;10:849. [PMID: 31699962 DOI: 10.1038/s41419-019-2086-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 14.8] [Reference Citation Analysis]
167 Yaguchi K, Sasaki T, Ogashiwa T, Nishio M, Hashimoto Y, Ikeda A, Izumi M, Hanzawa A, Shibata N, Yonezawa H, Sakamaki K, Tateishi Y, Numata K, Maeda S, Kimura H, Kunisaki R. Correlation between the macroscopic severity of Crohn's disease in resected intestine and bowel wall thickness evaluated by water-immersion ultrasonography. Scand J Gastroenterol 2019;54:1331-8. [PMID: 31656106 DOI: 10.1080/00365521.2019.1683224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
168 Grass F, Fletcher JG, Alsughayer A, Petersen M, Bruining DH, Bartlett DJ, Mathis KL, Lightner AL. Development of an Objective Model to Define Near-Term Risk of Ileocecal Resection in Patients with Terminal Ileal Crohn Disease. Inflamm Bowel Dis 2019;25:1845-53. [PMID: 31050733 DOI: 10.1093/ibd/izz079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
169 Ellermann M, Gharaibeh RZ, Fulbright L, Dogan B, Moore LN, Broberg CA, Lopez LR, Rothemich AM, Herzog JW, Rogala A, Gordon IO, Rieder F, Brouwer CR, Simpson KW, Jobin C, Sartor RB, Arthur JC. Yersiniabactin-Producing Adherent/Invasive Escherichia coli Promotes Inflammation-Associated Fibrosis in Gnotobiotic Il10-/- Mice. Infect Immun 2019;87:e00587-19. [PMID: 31481410 DOI: 10.1128/IAI.00587-19] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
170 Raselli T, Wyss A, Gonzalez Alvarado MN, Weder B, Mamie C, Spalinger MR, Van Haaften WT, Dijkstra G, Sailer AW, Imenez Silva PH, Wagner CA, Tosevski V, Leibl S, Scharl M, Rogler G, Hausmann M, Misselwitz B. The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis. J Crohns Colitis 2019;13:1186-200. [PMID: 31220227 DOI: 10.1093/ecco-jcc/jjz039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
171 Ellermann M, Gharaibeh RZ, Fulbright L, Dogan B, Moore LN, Broberg CA, Lopez LR, Rothemich AM, Herzog JW, Rogala A, Gordon IO, Rieder F, Brouwer CR, Simpson KW, Jobin C, Sartor RB, Arthur JC. Yersiniabactin producing AIEC promote inflammation-associated fibrosis in gnotobioticIl10−/−mice.. [DOI: 10.1101/723148] [Reference Citation Analysis]
172 Strowitzki MJ, Ritter AS, Kimmer G, Schneider M. Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease? Pharmacol Res 2019;147:104364. [PMID: 31376431 DOI: 10.1016/j.phrs.2019.104364] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
173 Lo Y, Sauve JP, Menzies SC, Steiner TS, Sly LM. Phosphatidylinositol 3-kinase p110δ drives intestinal fibrosis in SHIP deficiency. Mucosal Immunol 2019;12:1187-200. [PMID: 31358861 DOI: 10.1038/s41385-019-0191-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
174 Yan SC, Wang YJ, Li YJ, Cai WY, Weng XG, Li Q, Chen Y, Yang Q, Zhu XX. Dihydroartemisinin Regulates the Th/Treg Balance by Inducing Activated CD4+ T cell Apoptosis via Heme Oxygenase-1 Induction in Mouse Models of Inflammatory Bowel Disease. Molecules 2019;24:E2475. [PMID: 31284478 DOI: 10.3390/molecules24132475] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
175 Bettenworth D, Bokemeyer A, Baker M, Mao R, Parker CE, Nguyen T, Ma C, Panés J, Rimola J, Fletcher JG, Jairath V, Feagan BG, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut 2019;68:1115-26. [PMID: 30944110 DOI: 10.1136/gutjnl-2018-318081] [Cited by in Crossref: 120] [Cited by in F6Publishing: 94] [Article Influence: 30.0] [Reference Citation Analysis]
176 Argollo M, Gilardi D, Roda G, Fiorino G, Peyrin-biroulet L, Danese S. Anti-fibrotic Drugs for Crohn’s Disease: Ready for Prime Time? CPD 2019;25:47-56. [DOI: 10.2174/1381612825666190308100844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
177 Pizarro TT, Stappenbeck TS, Rieder F, Rosen MJ, Colombel JF, Donowitz M, Towne J, Mazmanian SK, Faith JJ, Hodin RA, Garrett WS, Fichera A, Poritz LS, Cortes CJ, Shtraizent N, Honig G, Snapper SB, Hurtado-Lorenzo A, Salzman NH, Chang EB. Challenges in IBD Research: Preclinical Human IBD Mechanisms. Inflamm Bowel Dis 2019;25:S5-S12. [PMID: 31095706 DOI: 10.1093/ibd/izz075] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 8.8] [Reference Citation Analysis]
178 Zittan E, Muir J, Milgrom R, Berns M, Gralnek IM, Cohen Z, Riddell R, Silverberg MS. Preoperative exposure to anti-tumor necrosis factor therapy in ulcerative colitis patients undergoing ileal pouch-anal anastomosis (IPAA) is not associated with histological fibrosis: A case control study. International Journal of Surgery 2019;65:80-5. [DOI: 10.1016/j.ijsu.2019.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
179 Friedrich M, Pohin M, Powrie F. Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. Immunity 2019;50:992-1006. [DOI: 10.1016/j.immuni.2019.03.017] [Cited by in Crossref: 257] [Cited by in F6Publishing: 204] [Article Influence: 64.3] [Reference Citation Analysis]
180 Di Fusco D, Dinallo V, Marafini I, Figliuzzi MM, Romano B, Monteleone G. Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease. Front Pharmacol 2019;10:305. [PMID: 30983999 DOI: 10.3389/fphar.2019.00305] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
181 Li J, Mao R, Kurada S, Wang J, Lin S, Chandra J, Rieder F. Pathogenesis of fibrostenosing Crohn's disease. Transl Res 2019;209:39-54. [PMID: 30981697 DOI: 10.1016/j.trsl.2019.03.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
182 Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carlé B, Knieling F, Claussen J, Klimowicz AC, Zheng J, Baum P, Meyer S, Schürmann S, Friedrich O, Waldner MJ, Rath T, Wirtz S, Kollias G, Ekici AB, Atreya R, Raymond EL, Mbow ML, Neurath MF, Neufert C. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation. Gastroenterology 2019;156:1082-1097.e11. [PMID: 30452921 DOI: 10.1053/j.gastro.2018.11.029] [Cited by in Crossref: 104] [Cited by in F6Publishing: 103] [Article Influence: 26.0] [Reference Citation Analysis]
183 Mao R, Rieder F. Cooling Down the Hot Potato: Anti-Interleukin 36 Therapy Prevents and Treats Experimental Intestinal Fibrosis. Gastroenterology 2019;156:871-3. [PMID: 30776349 DOI: 10.1053/j.gastro.2019.02.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
184 Mao R, Kurada S, Gordon IO, Baker ME, Gandhi N, McDonald C, Coffey JC, Rieder F. The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease. Inflamm Bowel Dis 2019;25:421-6. [PMID: 30346528 DOI: 10.1093/ibd/izy331] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 18.8] [Reference Citation Analysis]
185 Ma C, Jairath V, Click B, Hirota SA, Lu C, Parker CE, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium. Targeting anti-fibrotic pathways in Crohn's disease - The final frontier? Best Pract Res Clin Gastroenterol 2019;38-39:101603. [PMID: 31327400 DOI: 10.1016/j.bpg.2019.02.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
186 Imai J, Kitamoto S, Sugihara K, Nagao-Kitamoto H, Hayashi A, Morhardt TL, Kuffa P, Higgins PDR, Barnich N, Kamada N. Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis. Mucosal Immunol 2019;12:632-43. [PMID: 30742042 DOI: 10.1038/s41385-019-0138-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
187 Colombel JF, Shin A, Gibson PR. AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clin Gastroenterol Hepatol 2019;17:380-390.e1. [PMID: 30099108 DOI: 10.1016/j.cgh.2018.08.001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 17.5] [Reference Citation Analysis]
188 Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F, Eliakim R, Ellul P, González-Lama Y, Gordon H, Halligan S, Katsanos K, Kopylov U, Kotze PG, Krustinš E, Laghi A, Limdi JK, Rieder F, Rimola J, Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019;13:144-64. [PMID: 30137275 DOI: 10.1093/ecco-jcc/jjy113] [Cited by in Crossref: 568] [Cited by in F6Publishing: 431] [Article Influence: 142.0] [Reference Citation Analysis]
189 Crews NR, Bohm ME. Complications of Inflammatory Bowel Disease: Initial Medical Management and Role of Endoscopy. Multidisciplinary Approaches to Common Surgical Problems 2019. [DOI: 10.1007/978-3-030-12823-4_12] [Reference Citation Analysis]
190 Zhang L, Wu T. Inflammatory Bowel Disease. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases 2019. [DOI: 10.1007/978-3-030-15573-5_15] [Reference Citation Analysis]
191 Böhmig M. Mechanisms of Disease, Etiology and Clinical Manifestations. Inflammatory Bowel Disease Nursing Manual 2019. [DOI: 10.1007/978-3-319-75022-4_3] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
192 Kurada SV, Rieder F. Fibrosis and Stricturing Disease in Crohn’s Disease. Biomarkers in Inflammatory Bowel Diseases 2019. [DOI: 10.1007/978-3-030-11446-6_7] [Reference Citation Analysis]
193 Guler R, Mpotje T, Ozturk M, Nono JK, Parihar SP, Chia JE, Abdel Aziz N, Hlaka L, Kumar S, Roy S, Penn-Nicholson A, Hanekom WA, Zak DE, Scriba TJ, Suzuki H, Brombacher F. Batf2 differentially regulates tissue immunopathology in Type 1 and Type 2 diseases. Mucosal Immunol 2019;12:390-402. [PMID: 30542107 DOI: 10.1038/s41385-018-0108-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
194 Hutter S, van Haaften WT, Hünerwadel A, Baebler K, Herfarth N, Raselli T, Mamie C, Misselwitz B, Rogler G, Weder B, Dijkstra G, Meier CF, de Vallière C, Weber A, Imenez Silva PH, Wagner CA, Frey-Wagner I, Ruiz PA, Hausmann M. Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis. J Crohns Colitis 2018;12:1348-58. [PMID: 30165600 DOI: 10.1093/ecco-jcc/jjy118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
195 Lenti MV, Di Sabatino A. Intestinal fibrosis. Mol Aspects Med 2019;65:100-9. [PMID: 30385174 DOI: 10.1016/j.mam.2018.10.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 9.4] [Reference Citation Analysis]
196 Zhang HJ, Zhang YN, Zhou H, Guan L, Li Y, Sun MJ. IL-17A Promotes Initiation and Development of Intestinal Fibrosis Through EMT. Dig Dis Sci 2018;63:2898-909. [PMID: 30097894 DOI: 10.1007/s10620-018-5234-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
197 Bonafiglia QA, Lourenssen SR, Hurlbut DJ, Blennerhassett MG. Epigenetic modification of intestinal smooth muscle cell phenotype during proliferation. American Journal of Physiology-Cell Physiology 2018;315:C722-33. [DOI: 10.1152/ajpcell.00216.2018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
198 Hotta Y, Uchiyama K, Takagi T, Kashiwagi S, Nakano T, Mukai R, Toyokawa Y, Yasuda T, Ueda T, Suyama Y, Murakami T, Tanaka M, Majima A, Doi T, Hirai Y, Mizushima K, Morita M, Higashimura Y, Inoue K, Fukui A, Okayama T, Katada K, Kamada K, Handa O, Ishikawa T, Naito Y, Itoh Y. Transforming growth factor β1-induced collagen production in myofibroblasts is mediated by reactive oxygen species derived from NADPH oxidase 4. Biochem Biophys Res Commun 2018;506:557-62. [PMID: 30361098 DOI: 10.1016/j.bbrc.2018.10.116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
199 Hünerwadel A, Fagagnini S, Rogler G, Lutz C, Jaeger SU, Mamie C, Weder B, Ruiz PA, Hausmann M. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis. Sci Rep 2018;8:15182. [PMID: 30315190 DOI: 10.1038/s41598-018-33452-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
200 Macias-Ceja DC, Ortiz-Masiá D, Salvador P, Gisbert-Ferrándiz L, Hernández C, Hausmann M, Rogler G, Esplugues JV, Hinojosa J, Alós R, Navarro F, Cosin-Roger J, Calatayud S, Barrachina MD. Succinate receptor mediates intestinal inflammation and fibrosis. Mucosal Immunol 2019;12:178-87. [PMID: 30279517 DOI: 10.1038/s41385-018-0087-3] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
201 Zhang X, Ko HM, Torres J, Panchal HJ, Cai Z, Wagner M, Sands BE, Colombel J, Cho J, Taouli B, Harpaz N. Luminally polarized mural and vascular remodeling in ileal strictures of Crohn's disease. Human Pathology 2018;79:42-9. [DOI: 10.1016/j.humpath.2018.03.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
202 Baker ME, Fletcher JG, Al-hawary M, Bruining D. Interdisciplinary Updates in Crohn’s Disease Reporting Nomenclature, and Cross-Sectional Disease Monitoring. Radiologic Clinics of North America 2018;56:691-707. [DOI: 10.1016/j.rcl.2018.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Rieder F, Bettenworth D, Ma C, Parker CE, Williamson LA, Nelson SA, van Assche G, Di Sabatino A, Bouhnik Y, Stidham RW, Dignass A, Rogler G, Taylor SA, Stoker J, Rimola J, Baker ME, Fletcher JG, Panes J, Sandborn WJ, Feagan BG, Jairath V. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Aliment Pharmacol Ther 2018;48:347-57. [PMID: 29920726 DOI: 10.1111/apt.14853] [Cited by in Crossref: 111] [Cited by in F6Publishing: 80] [Article Influence: 22.2] [Reference Citation Analysis]
204 Mikami Y, Takada Y, Hagihara Y, Kanai T. Innate lymphoid cells in organ fibrosis. Cytokine Growth Factor Rev 2018;42:27-36. [PMID: 30104153 DOI: 10.1016/j.cytogfr.2018.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
205 Danese S, Bonovas S, Lopez A, Fiorino G, Sandborn WJ, Rubin DT, Kamm MA, Colombel JF, Sands BE, Vermeire S, Panes J, Rogler G, D'Haens G, Peyrin-Biroulet L. Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease. Gastroenterology 2018;155:76-87. [PMID: 29601825 DOI: 10.1053/j.gastro.2018.03.032] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
206 Sousa HT, Brito J, Magro F. New cross-sectional imaging in IBD. Curr Opin Gastroenterol 2018;34:194-207. [PMID: 29846256 DOI: 10.1097/MOG.0000000000000440] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
207 Lian L, Huang Q, Zhang L, Qin H, He X, He X, Ke J, Xie M, Lan P. Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease. Dig Dis Sci 2018;63:1821-34. [PMID: 29704139 DOI: 10.1007/s10620-018-5082-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
208 Liefferinckx C, Franchimont D. Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2018;24:1428-39. [PMID: 29788122 DOI: 10.1093/ibd/izy109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
209 Pouillon L, Laurent V, Pouillon M, Bossuyt P, Bonifacio C, Danese S, Deepak P, Loftus EV, Bruining DH, Peyrin-biroulet L. Diffusion-weighted MRI in inflammatory bowel disease. The Lancet Gastroenterology & Hepatology 2018;3:433-43. [DOI: 10.1016/s2468-1253(18)30054-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
210 Li C. The Role of Endoplasmic Reticulum Stress in the Development of Fibrosis in Crohn’s Disease. Exploratory Research and Hypothesis in Medicine 2018;3:33-41. [DOI: 10.14218/erhm.2018.00003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
211 Auci DL, Egilmez NK, Dryden GW. Anti-Fibrotic Potential of All Trans Retinoic Acid in Inflammatory Bowel Disease. J Gastroenterol Pancreatol Liver Disord. 2018;6 . [PMID: 30740522 DOI: 10.15226/2374-815x/6/3/001126] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
212 Wagner M, Ko HM, Chatterji M, Besa C, Torres J, Zhang X, Panchal H, Hectors S, Cho J, Colombel JF, Harpaz N, Taouli B. Magnetic Resonance Imaging Predicts Histopathological Composition of Ileal Crohn's Disease. J Crohns Colitis 2018;12:718-29. [PMID: 29300851 DOI: 10.1093/ecco-jcc/jjx186] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
213 Gordon IO, Agrawal N, Willis E, Goldblum JR, Lopez R, Allende D, Liu X, Patil DY, Yerian L, El-Khider F, Fiocchi C, Rieder F. Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation. Aliment Pharmacol Ther 2018;47:922-39. [PMID: 29411405 DOI: 10.1111/apt.14526] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 14.0] [Reference Citation Analysis]
214 Nascimbeni R, Casiraghi S, Cannatelli R, Lanzarotto F, Casella C, Ricci C, Villanacci V, Portolani N, Moneghini D. Ulcerative colitis and the aging-related development of colonic diverticula. Int J Colorectal Dis 2018;33:1277-83. [PMID: 29602977 DOI: 10.1007/s00384-018-3040-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
215 Guan Y, Tan Y, Liu W, Yang J, Wang D, Pan D, Sun Y, Zheng C. NF-E2-Related Factor 2 Suppresses Intestinal Fibrosis by Inhibiting Reactive Oxygen Species-Dependent TGF-β1/SMADs Pathway. Dig Dis Sci 2018;63:366-80. [PMID: 28815354 DOI: 10.1007/s10620-017-4710-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
216 Latella G. Redox Imbalance in Intestinal Fibrosis: Beware of the TGFβ-1, ROS, and Nrf2 Connection. Dig Dis Sci 2018;63:312-20. [PMID: 29273848 DOI: 10.1007/s10620-017-4887-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
217 Hirota SA. TRPing Up Fibrosis: A Novel Role for TRPA1 in Intestinal Myofibroblasts. Cell Mol Gastroenterol Hepatol 2018;5:365. [PMID: 29552624 DOI: 10.1016/j.jcmgh.2018.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
218 Orlando S, Fraquelli M, Coletta M, Branchi F, Magarotto A, Conti CB, Mazza S, Conte D, Basilisco G, Caprioli F. Ultrasound Elasticity Imaging Predicts Therapeutic Outcomes of Patients With Crohn's Disease Treated With Anti-Tumour Necrosis Factor Antibodies. J Crohns Colitis 2018;12:63-70. [PMID: 28961950 DOI: 10.1093/ecco-jcc/jjx116] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
219 Rogler G. Challenges of Translation of Anti-Fibrotic Therapies into Clinical Practice in IBD. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_20] [Reference Citation Analysis]
220 Rieder F. Fibrostenotic Inflammatory Bowel Disease: A Cinderella Story. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_1] [Reference Citation Analysis]
221 Bettenworth D. Animal Models and Sources of Mesenchymal Cells in Intestinal Fibrosis. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_9] [Reference Citation Analysis]
222 Bernardazzi C, Castro F, de Souza HS. Environmental Factors and Their Influence on Intestinal Fibrosis. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_8] [Reference Citation Analysis]
223 Achkar J. Postoperative Crohn's Disease Recurrence and Role of Endoscopy. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications 2018. [DOI: 10.1016/b978-0-12-811388-2.00025-7] [Reference Citation Analysis]
224 Magro F, António T. Fibrosis in Ulcerative Colitis. Fibrostenotic Inflammatory Bowel Disease 2018. [DOI: 10.1007/978-3-319-90578-5_10] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
225 Ko JZ, Abraham JP, Shih DQ. Pathogenesis of Crohn's Disease- and Ulcerative Colitis-Related Strictures. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications 2018. [DOI: 10.1016/b978-0-12-811388-2.00003-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
226 Rubín de Célix Vargas C, Martín García P, del Campo L, García-buey L. String sign of Kantor in a patient with Crohn�s disease. Rev Esp Enferm Dig 2018;110. [DOI: 10.17235/reed.2018.5598/2018] [Reference Citation Analysis]
227 Kurahara LH, Hiraishi K, Hu Y, Koga K, Onitsuka M, Doi M, Aoyagi K, Takedatsu H, Kojima D, Fujihara Y, Jian Y, Inoue R. Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn's Disease. Cell Mol Gastroenterol Hepatol 2018;5:299-318. [PMID: 29552620 DOI: 10.1016/j.jcmgh.2017.12.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
228 Lutz C, Weder B, Hünerwadel A, Fagagnini S, Lang B, Beerenwinkel N, Rossel JB, Rogler G, Misselwitz B, Hausmann M. Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development. Sci Rep 2017;7:17678. [PMID: 29247242 DOI: 10.1038/s41598-017-17755-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
229 Yang J, Zhou CZ, Zhu R, Fan H, Liu XX, Duan XY, Tang Q, Shou ZX, Zuo DM. miR-200b-containing microvesicles attenuate experimental colitis associated intestinal fibrosis by inhibiting epithelial-mesenchymal transition. J Gastroenterol Hepatol 2017;32:1966-74. [PMID: 28370348 DOI: 10.1111/jgh.13797] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
230 Fluxá D, Simian D, Flores L, Ibáñez P, Lubascher J, Figueroa C, Kronberg U, Pizarro G, Castro M, Piottante A, Vial MT, Quera R. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis. J Dig Dis 2017;18:634-41. [PMID: 28949435 DOI: 10.1111/1751-2980.12546] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
231 Rieder F. ROCKing the Field of Intestinal Fibrosis or Between a ROCK and a Hard Place? Gastroenterology 2017;153:895-7. [PMID: 28867272 DOI: 10.1053/j.gastro.2017.08.056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
232 Holvoet T, Devriese S, Castermans K, Boland S, Leysen D, Vandewynckel YP, Devisscher L, Van den Bossche L, Van Welden S, Dullaers M, Vandenbroucke RE, De Rycke R, Geboes K, Bourin A, Defert O, Hindryckx P, De Vos M, Laukens D. Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor. Gastroenterology 2017;153:1054-67. [PMID: 28642198 DOI: 10.1053/j.gastro.2017.06.013] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 11.7] [Reference Citation Analysis]
233 Bailey J. Editorial: Factors Promoting Development of Fibrosis in Crohn’s Disease. Front Med 2017;4. [DOI: 10.3389/fmed.2017.00160] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
234 Rogler G, Hausmann M. Factors Promoting Development of Fibrosis in Crohn's Disease. Front Med (Lausanne) 2017;4:96. [PMID: 28736729 DOI: 10.3389/fmed.2017.00096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
235 Latella G, Rieder F. Intestinal fibrosis: ready to be reversed. Curr Opin Gastroenterol 2017;33:239-45. [PMID: 28402994 DOI: 10.1097/MOG.0000000000000363] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
236 Triadafilopoulos G, Eisenstat S, Dormady S, Sinha R, Komlos F, Lombard C. When It Rains It Pours: Evolving, Complicated Small Intestinal Crohn's Disease. Dig Dis Sci 2017;62:577-82. [PMID: 28058597 DOI: 10.1007/s10620-016-4444-3] [Reference Citation Analysis]
237 Manresa MC, Taylor CT. Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function. Cell Mol Gastroenterol Hepatol 2017;3:303-15. [PMID: 28462372 DOI: 10.1016/j.jcmgh.2017.02.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
238 Colombel JF, Mahadevan U. Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms. Gastroenterology 2017;152:309-12. [PMID: 27960091 DOI: 10.1053/j.gastro.2016.12.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 8.7] [Reference Citation Analysis]
239 [DOI: 10.1101/424820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]